These studies confirmed the tumor-promoting role of NRP-1 and showed that the targeting of NRP-1 can act directly on cancer cells or indirectly by modulating angiogenesis or immune cells in the TME, including Tregs, macrophages and CD8+ T cells [2,5,6,34,39]. Here, CD8A is linked to neoplasm.